{"id":70732,"date":"2023-02-27T22:35:01","date_gmt":"2023-02-27T21:35:01","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=70732"},"modified":"2023-02-28T11:35:27","modified_gmt":"2023-02-28T10:35:27","slug":"aifa-monitoraggio-spesa-farmaceutica-gennaio-ottobre-2022","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/aifa-monitoraggio-spesa-farmaceutica-gennaio-ottobre-2022\/","title":{"rendered":"AIFA. Pharmaceutical expenditure monitoring January-October 2022"},"content":{"rendered":"<p>The Italian Medicines Agency (Aifa) has published the \u00ab<a href=\"https:\/\/www.aifa.gov.it\/documents\/20142\/1735594\/Monitoraggio_Spesa_gennaio-ottobre-2022.pdf\" target=\"_blank\" rel=\"noopener\">Monitoring of national and regional pharmaceutical expenditure\u00bb referring to the period January-October 2022<\/a>. Pharmaceutical expenditure, calculated net of discounts, <img loading=\"lazy\" decoding=\"async\" class=\"wp-image-70735 alignright\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/02\/monitoraggio-spesa-farmaci-ott-22.png\" alt=\"\" width=\"512\" height=\"393\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/02\/monitoraggio-spesa-farmaci-ott-22.png 654w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2023\/02\/monitoraggio-spesa-farmaci-ott-22-300x230.png 300w\" sizes=\"auto, (max-width: 512px) 100vw, 512px\" \/>of the total co-participation and pay-back paid to the Regions by pharmaceutical companies is 6,341.3 million euros.<\/p>\n<p>This highlights a slight increase, compared to the previous year, of +69.2 million euros, &quot;returning to 2020 levels&quot;. The number of prescriptions disbursed (465.2 million) showed the same trend with respect to this increase, which shows a change of +2.0% on 2021. The incidence of the ticket, i.e. the &quot;out of pocket&quot; expense of patients, increased by +1.4%. As for drug consumption, the number of daily doses shows an increase of +0.2%, equal to an increase of 39.7 million dispensed.<\/p>\n<h2 class=\"h3\">Regional trend of approved pharmaceuticals<\/h2>\n<p>With reference to the regional approved pharmaceutical expenditure incurred through the payment of the summary accounting slip to private and public territorial pharmacies, the Aifa report shows that the Regions with the greatest percentage increase are Lombardy (+4.4%), PA Trento (+3, 9%) and Molise (+3.5%).<\/p>\n<p>The Region with the greatest decline is Umbria (-4.6%). In most of the Regions there is an increasing trend of the concessions, with a recovery compared to the negative trend highlighted in the previous year. Other regions with a positive gap include Abruzzo and Emilia-Romagna (+2.6%), Sardinia (+2.2%) and Tuscany (+2.0%). Valle d&#039;Aosta and Liguria (+0.1%), Calabria (+0.2%) and Puglia (+0.4%) show a slight increase.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>L\u2019Agenzia italiana del farmaco (Aifa) ha pubblicato il \u00abMonitoraggio della spesa farmaceutica nazionale e regionale\u00bb riferito al periodo gennaio-ottobre 2022. La spesa farmaceutica, calcolata al netto degli sconti, della compartecipazione totale e del pay-back versato alle Regioni dalle aziende farmaceutiche, \u00e8 di 6.341,3 milioni di euro. Ci\u00f2 evidenzia un lieve aumento, rispetto all\u2019anno precedente, di &hellip;<\/p>","protected":false},"author":4,"featured_media":66455,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[49,26],"class_list":["post-70732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-aifa","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/70732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=70732"}],"version-history":[{"count":3,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/70732\/revisions"}],"predecessor-version":[{"id":70736,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/70732\/revisions\/70736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/66455"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=70732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=70732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=70732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}